Find Isoorientin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Homoorientin, 4261-42-1, Lespecapitioside, Luteolin-6-c-glucoside, Luteolin 6-c-glucoside, 2-(3,4-dihydroxyphenyl)-6-beta-d-glucopyranosyl-5,7-dihydroxy-4h-1-benzopyran-4-one
Molecular Formula
C21H20O11
Molecular Weight
448.4  g/mol
InChI Key
ODBRNZZJSYPIDI-VJXVFPJBSA-N
FDA UNII
A37342TIX1

Isoorientin
isoorientin is a natural product found in Carex fraseriana, Itea omeiensis, and other organisms with data available.
1 2D Structure

Isoorientin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one
2.1.2 InChI
InChI=1S/C21H20O11/c22-6-14-17(27)19(29)20(30)21(32-14)16-11(26)5-13-15(18(16)28)10(25)4-12(31-13)7-1-2-8(23)9(24)3-7/h1-5,14,17,19-24,26-30H,6H2/t14-,17-,19+,20-,21+/m1/s1
2.1.3 InChI Key
ODBRNZZJSYPIDI-VJXVFPJBSA-N
2.1.4 Canonical SMILES
C1=CC(=C(C=C1C2=CC(=O)C3=C(O2)C=C(C(=C3O)C4C(C(C(C(O4)CO)O)O)O)O)O)O
2.1.5 Isomeric SMILES
C1=CC(=C(C=C1C2=CC(=O)C3=C(O2)C=C(C(=C3O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)O
2.2 Other Identifiers
2.2.1 UNII
A37342TIX1
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 6-glc-luteolin

2. Homoorientin

3. Iso-orientin

4. Luteolin-6-c-glucoside

2.3.2 Depositor-Supplied Synonyms

1. Homoorientin

2. 4261-42-1

3. Lespecapitioside

4. Luteolin-6-c-glucoside

5. Luteolin 6-c-glucoside

6. 2-(3,4-dihydroxyphenyl)-6-beta-d-glucopyranosyl-5,7-dihydroxy-4h-1-benzopyran-4-one

7. Chebi:17965

8. Luteolin-6-c-beta-d-glucoside

9. A37342tix1

10. Iso-orientin

11. (1s)-1,5-anhydro-1-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-chromen-6-yl]-d-glucitol

12. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-((2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)-4h-chromen-4-one

13. 2-[3,4-bis(oxidanyl)phenyl]-6-[(2s,3r,4r,5s,6r)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]-5,7-bis(oxidanyl)chromen-4-one

14. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one

15. Homoori-entin

16. Unii-a37342tix1

17. 4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-6-beta-d-glucopyranosyl-5,7-dihydroxy-

18. Mfcd00017433

19. Lutonaretin

20. Homoorientin; Isoorientin

21. Schembl23761

22. Mls002473101

23. Chembl239559

24. Isoorientin, Analytical Standard

25. Luteolin 6-c-bet.-d-glucoside

26. Isoorientin, >=98% (hplc)

27. Dtxsid50962609

28. 4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-6-.beta.-d-glucopyranosyl-5,7-dihydroxy-

29. Luteolin-6-c-b-d-glucopyranoside

30. Hms2225d20

31. Hy-n0767

32. Zinc4349262

33. Isoorientin, >=98.0% (hplc)

34. Bdbm50487756

35. S9248

36. Akos015896766

37. Ccg-208392

38. Cs-7515

39. Ncgc00163566-01

40. Ac-34983

41. As-56302

42. Smr001397203

43. I1087

44. C01821

45. 261h421

46. Q-100474

47. Q3155592

48. Isoorientin, Primary Pharmaceutical Reference Standard

49. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one

50. H9r

2.4 Create Date
2004-09-16
3 Chemical and Physical Properties
Molecular Weight 448.4 g/mol
Molecular Formula C21H20O11
XLogP3-0.2
Hydrogen Bond Donor Count8
Hydrogen Bond Acceptor Count11
Rotatable Bond Count3
Exact Mass448.10056145 g/mol
Monoisotopic Mass448.10056145 g/mol
Topological Polar Surface Area197 Ų
Heavy Atom Count32
Formal Charge0
Complexity729
Isotope Atom Count0
Defined Atom Stereocenter Count5
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty